|
Federal
Register Notices > Notices of
Registration - 2007
>
Noramco Inc.
FR Doc E7-9631 [Federal Register: May 18, 2007 (Volume 72, Number 96)]
[Notices] [Page 28075-28076] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18my07-101]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 15, 2006, and published in the Federal Register on
August 22, 2006, (71 FR 48947), Noramco Inc., Division of Ortho-McNeil, Inc.,
500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by
renewal, and by separate correspondence dated June 2,
[[Page 28076]]
2006, and July 25, 2006, to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled substances
listed in schedule I and II:
|
Drug
|
Schedule
|
|
Codeine-N-Oxide (9053)
|
I
|
|
Morphine-N-Oxide (9307)
|
I
|
|
Codeine (9050)
|
II |
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Dihydromorphine (9145)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Thebaine (9333)
|
II
|
|
Morphine (9300)
|
II
|
|
Oxymorphone (9652)
|
II
|
The company plans to bulk manufacture the above listed controlled substances
for sale and distribution to manufacturers for product development and
formulation.
By letter dated January 4, 2007, Noramco has withdrawn their request for
Amphetamine (1100) and Methylphenidate (1724).
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Noramco Inc. to
manufacture the listed basic classes of controlled substances is consistent with
the public interest at this time. DEA has investigated Noramco Inc. to ensure
that the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's physical
security systems, verification of the company's compliance with State and local
laws, and a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823,
and in accordance with 21
CFR 1301.33(a), the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: May 8, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-9631 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|